Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5U77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,297
Award facts
- Contract value 100% obligated
- $16,297.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,297.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL) with an ultimate completion date of December 24, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
Dupixent is a specialty pharmaceutical used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, reflecting the breadth of medical products that AmerisourceBergen supplies to support military healthcare operations worldwide. The company's federal contract portfolio demonstrates consistent capability to deliver brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies through competitive, firm fixed-price arrangements with the DLA Medical Supply Chain. This delivery order is one of numerous transactions executed under AmerisourceBergen's comprehensive prime vendor agreement, which enables flexible pharmaceutical support across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5U77?
SPE2DR26F5U77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F5U77 worth?
The government has obligated $16,297 on SPE2DR26F5U77.
Is contract SPE2DR26F5U77 an order under another contract?
Yes. SPE2DR26F5U77 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5U77 competed?
The extent of competition for SPE2DR26F5U77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award